Shopping Cart
Remove All
Your shopping cart is currently empty
Atrimustine, a conjugate of chlorambucil and β-estradiol benzoate, possesses antitumor activity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $916 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,190 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $1,860 | 6-8 weeks | 6-8 weeks |
| Description | Atrimustine, a conjugate of chlorambucil and β-estradiol benzoate, possesses antitumor activity. |
| In vitro | Atrimustine (Bestrabucil), a conjugate combining chlorambucil with β-estradiol benzoate, exhibits a high affinity for tumor cells, thereby boosting the antitumor efficacy of chlorambucil[1]. This compound demonstrates concentration-dependent inhibition of growth factor production in Shionogi carcinoma 115 (SC-115) cells, an androgen-responsive cancer cell line, across a range of 100 nM to 10 μM. This inhibition is evidenced through a 3H-thymidine uptake assay[2], highlighting Atrimustine's potential in hindering cancer cell proliferation. |
| Synonyms | KM2210, Bestrabucil |
| Molecular Weight | 720.72 |
| Formula | C41H47Cl2NO6 |
| Cas No. | 75219-46-4 |
| Relative Density. | 1.1424 g/cm3 (Estimated) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.